25 XP   0   0   10

Shinpoong Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Shinpoong together

PenkeI guess you are interested in Shinpoong Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Shinpoong Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Shinpoong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shinpoong Pharmaceutical Co Ltd.

Quick analysis of Shinpoong (30 sec.)










What can you expect buying and holding a share of Shinpoong? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
14.8%

What is your share worth?

Current worth
₩5,495.77
Expected worth in 1 year
₩4,278.50
How sure are you?
40.7%

+ What do you gain per year?

Total Gains per Share
₩-1,217.27
Return On Investment
-5.2%

For what price can you sell your share?

Current Price per Share
₩23,600.00
Expected price per share
₩17,530 - ₩39,000
How sure are you?
50%

1. Valuation of Shinpoong (5 min.)




Live pricePrice per Share (EOD)

₩23,600.00

Intrinsic Value Per Share

₩-25,071.88 - ₩-29,765.63

Total Value Per Share

₩-19,576.11 - ₩-24,269.86

2. Growth of Shinpoong (5 min.)




Is Shinpoong growing?

Current yearPrevious yearGrowGrow %
How rich?$189.5m$238.7m-$25.5m-12.0%

How much money is Shinpoong making?

Current yearPrevious yearGrowGrow %
Making money-$10m-$6.3m-$3.6m-36.8%
Net Profit Margin-28.7%-16.7%--

How much money comes from the company's main activities?

3. Financial Health of Shinpoong (5 min.)




What can you expect buying and holding a share of Shinpoong? (5 min.)

Welcome investor! Shinpoong's management wants to use your money to grow the business. In return you get a share of Shinpoong.

What can you expect buying and holding a share of Shinpoong?

First you should know what it really means to hold a share of Shinpoong. And how you can make/lose money.

Speculation

The Price per Share of Shinpoong is ₩23,600. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Shinpoong.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Shinpoong, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩5,495.77. Based on the TTM, the Book Value Change Per Share is ₩-304.32 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-120.77 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Shinpoong.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.470.0%-0.200.0%-0.130.0%-0.070.0%-0.050.0%
Usd Book Value Change Per Share-0.520.0%-0.210.0%-0.080.0%0.040.0%0.140.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.0%0.010.0%
Usd Total Gains Per Share-0.520.0%-0.210.0%-0.080.0%0.060.0%0.150.0%
Usd Price Per Share14.46-18.48-33.57-35.60-27.44-
Price to Earnings Ratio-7.65--34.96--100.05-516.83-391.82-
Price-to-Total Gains Ratio-27.78--146.46--430.72--181.22--114.74-
Price to Book Ratio3.76-4.25-6.90-7.42-5.85-
Price-to-Total Gains Ratio-27.78--146.46--430.72--181.22--114.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.52
Number of shares60
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.210.04
Usd Total Gains Per Share-0.210.06
Gains per Quarter (60 shares)-12.783.53
Gains per Year (60 shares)-51.1314.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-51-614114
20-102-11272118
30-153-163113232
40-205-214144246
50-256-265185360
60-307-316216474
70-358-367257488
80-409-4182885102
90-460-4693295116
100-511-52035106130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%10.010.00.050.0%15.012.00.055.6%15.012.00.055.6%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%7.013.00.035.0%11.016.00.040.7%11.016.00.040.7%
Dividend per Share0.00.04.00.0%1.00.011.08.3%4.00.016.020.0%4.00.023.014.8%4.00.023.014.8%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%7.013.00.035.0%11.016.00.040.7%11.016.00.040.7%

Fundamentals of Shinpoong

About Shinpoong Pharmaceutical Co Ltd

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-15 01:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Shinpoong Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Shinpoong earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -67.0% means that ₩-0.67 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is -67.0%. The company is making a huge loss. -2
  • The TTM is -28.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-67.0%TTM-28.7%-38.3%
TTM-28.7%YOY-16.7%-12.0%
TTM-28.7%5Y-9.2%-19.5%
5Y-9.2%10Y-6.6%-2.6%
1.1.2. Return on Assets

Shows how efficient Shinpoong is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • -9.5% Return on Assets means that Shinpoong generated ₩-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is -9.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-3.9%-5.5%
TTM-3.9%YOY-2.4%-1.5%
TTM-3.9%5Y-1.3%-2.7%
5Y-1.3%10Y-0.9%-0.4%
1.1.3. Return on Equity

Shows how efficient Shinpoong is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • -12.3% Return on Equity means Shinpoong generated ₩-0.12 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is -12.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.3%TTM-5.0%-7.3%
TTM-5.0%YOY-2.7%-2.3%
TTM-5.0%5Y-1.5%-3.5%
5Y-1.5%10Y-1.0%-0.4%

1.2. Operating Efficiency of Shinpoong Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Shinpoong is operating .

  • Measures how much profit Shinpoong makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-4.6%+4.6%
TTM-4.6%YOY-16.1%+11.5%
TTM-4.6%5Y-1.8%-2.8%
5Y-1.8%10Y-0.3%-1.5%
1.2.2. Operating Ratio

Measures how efficient Shinpoong is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.91 means that the operating costs are ₩1.91 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 1.911. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.529. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.911TTM1.529+0.382
TTM1.529YOY1.157+0.372
TTM1.5295Y1.450+0.079
5Y1.45010Y1.475-0.024

1.3. Liquidity of Shinpoong Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Shinpoong is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.60 means the company has ₩2.60 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 2.604. The company is able to pay all its short-term debts. +1
  • The TTM is 3.217. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.604TTM3.217-0.613
TTM3.217YOY7.330-4.113
TTM3.2175Y4.349-1.132
5Y4.34910Y3.628+0.721
1.3.2. Quick Ratio

Measures if Shinpoong is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.18 means the company can pay off ₩1.18 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 1.184. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.513. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.184TTM1.513-0.329
TTM1.513YOY4.270-2.757
TTM1.5135Y2.551-1.038
5Y2.55110Y2.150+0.401

1.4. Solvency of Shinpoong Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Shinpoong assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Shinpoong to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.23 means that Shinpoong assets are financed with 22.7% credit (debt) and the remaining percentage (100% - 22.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 0.227. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.188. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.227TTM0.188+0.039
TTM0.188YOY0.101+0.086
TTM0.1885Y0.252-0.064
5Y0.25210Y0.303-0.051
1.4.2. Debt to Equity Ratio

Measures if Shinpoong is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 29.4% means that company has ₩0.29 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The MRQ is 0.294. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.233. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.233+0.061
TTM0.233YOY0.113+0.120
TTM0.2335Y0.396-0.163
5Y0.39610Y0.508-0.111

2. Market Valuation of Shinpoong Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Shinpoong generates.

  • Above 15 is considered overpriced but always compare Shinpoong to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.65 means the investor is paying ₩-7.65 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The EOD is -8.745. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.652. Based on the earnings, the company is expensive. -2
  • The TTM is -34.958. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.745MRQ-7.652-1.093
MRQ-7.652TTM-34.958+27.306
TTM-34.958YOY-100.047+65.089
TTM-34.9585Y516.832-551.790
5Y516.83210Y391.823+125.008
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The EOD is -20.306. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.767. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -36.892. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-20.306MRQ-17.767-2.538
MRQ-17.767TTM-36.892+19.125
TTM-36.892YOY31.201-68.093
TTM-36.8925Y88.773-125.665
5Y88.77310Y74.096+14.677
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Shinpoong is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 3.76 means the investor is paying ₩3.76 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Shinpoong Pharmaceutical Co Ltd:

  • The EOD is 4.294. Based on the equity, the company is fair priced.
  • The MRQ is 3.757. Based on the equity, the company is fair priced.
  • The TTM is 4.247. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.294MRQ3.757+0.537
MRQ3.757TTM4.247-0.489
TTM4.247YOY6.897-2.650
TTM4.2475Y7.421-3.174
5Y7.42110Y5.853+1.568
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Shinpoong Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---743.355-304.317-59%-120.765-84%63.014-1280%203.547-465%
Book Value Per Share--5495.7686182.544-11%6923.542-21%6173.949-11%5689.972-3%
Current Ratio--2.6043.217-19%7.330-64%4.349-40%3.628-28%
Debt To Asset Ratio--0.2270.188+21%0.101+123%0.252-10%0.303-25%
Debt To Equity Ratio--0.2940.233+26%0.113+159%0.396-26%0.508-42%
Dividend Per Share----0%-0%21.070-100%15.608-100%
Eps---674.651-290.868-57%-179.502-73%-95.192-86%-68.553-90%
Free Cash Flow Per Share---290.561-202.342-30%-165.780-43%-128.619-56%-67.746-77%
Free Cash Flow To Equity Per Share---290.561-206.491-29%-175.090-40%-30.018-90%-2.157-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---29765.627--------
Intrinsic Value_10Y_min---25071.881--------
Intrinsic Value_1Y_max---1296.797--------
Intrinsic Value_1Y_min---1272.778--------
Intrinsic Value_3Y_max---5181.223--------
Intrinsic Value_3Y_min---4920.484--------
Intrinsic Value_5Y_max---10614.736--------
Intrinsic Value_5Y_min---9741.736--------
Market Cap46993028000.000-2065%1017446748850.0001300755165600.000-22%2363161728412.500-57%2501845212859.500-59%1929491823432.963-47%
Net Profit Margin---0.670-0.287-57%-0.167-75%-0.092-86%-0.066-90%
Operating Margin----0.0460%-0.1610%-0.0180%-0.0030%
Operating Ratio--1.9111.529+25%1.157+65%1.450+32%1.475+30%
Pb Ratio4.294+13%3.7574.247-12%6.897-46%7.421-49%5.853-36%
Pe Ratio-8.745-14%-7.652-34.958+357%-100.047+1207%516.832-101%391.823-102%
Price Per Share23600.000+13%20650.00026400.000-22%47962.500-57%50858.000-59%39198.889-47%
Price To Free Cash Flow Ratio-20.306-14%-17.767-36.892+108%31.201-157%88.773-120%74.096-124%
Price To Total Gains Ratio-31.748-14%-27.779-146.463+427%-430.722+1451%-181.224+552%-114.742+313%
Quick Ratio--1.1841.513-22%4.270-72%2.551-54%2.150-45%
Return On Assets---0.095-0.039-58%-0.024-74%-0.013-86%-0.009-90%
Return On Equity---0.123-0.050-59%-0.027-78%-0.015-88%-0.010-92%
Total Gains Per Share---743.355-304.317-59%-120.765-84%84.084-984%219.154-439%
Usd Book Value--189547501.283213234224.347-11%238791015.873-21%212658659.535-11%196587270.503-4%
Usd Book Value Change Per Share---0.520-0.213-59%-0.085-84%0.044-1280%0.142-465%
Usd Book Value Per Share--3.8474.328-11%4.846-21%4.322-11%3.983-3%
Usd Dividend Per Share----0%-0%0.015-100%0.011-100%
Usd Eps---0.472-0.204-57%-0.126-73%-0.067-86%-0.048-90%
Usd Free Cash Flow---10021350.577-6978703.970-30%-5717700.632-43%-4447825.655-56%-2331767.446-77%
Usd Free Cash Flow Per Share---0.203-0.142-30%-0.116-43%-0.090-56%-0.047-77%
Usd Free Cash Flow To Equity Per Share---0.203-0.145-29%-0.123-40%-0.021-90%-0.002-99%
Usd Market Cap32895119.600-2065%712212724.195910528615.920-22%1654213209.889-57%1751291649.002-59%1350644276.403-47%
Usd Price Per Share16.520+13%14.45518.480-22%33.574-57%35.601-59%27.439-47%
Usd Profit---23268525.770-10031942.585-57%-6343328.210-73%-3319048.674-86%-2386368.394-90%
Usd Revenue--34726190.56935040001.812-1%36625334.911-5%34517906.786+1%34014189.677+2%
Usd Total Gains Per Share---0.520-0.213-59%-0.085-84%0.059-984%0.153-439%
 EOD+3 -5MRQTTM+3 -29YOY+4 -285Y+8 -2610Y+8 -26

3.2. Fundamental Score

Let's check the fundamental score of Shinpoong Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.745
Price to Book Ratio (EOD)Between0-14.294
Net Profit Margin (MRQ)Greater than0-0.670
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.184
Current Ratio (MRQ)Greater than12.604
Debt to Asset Ratio (MRQ)Less than10.227
Debt to Equity Ratio (MRQ)Less than10.294
Return on Equity (MRQ)Greater than0.15-0.123
Return on Assets (MRQ)Greater than0.05-0.095
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Shinpoong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.804
Ma 20Greater thanMa 5026,855.000
Ma 50Greater thanMa 10021,923.600
Ma 100Greater thanMa 20021,100.300
OpenGreater thanClose24,500.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets350,083,640
Total Liabilities79,301,495
Total Stockholder Equity269,585,828
 As reported
Total Liabilities 79,301,495
Total Stockholder Equity+ 269,585,828
Total Assets = 350,083,640

Assets

Total Assets350,083,640
Total Current Assets198,935,276
Long-term Assets151,148,364
Total Current Assets
Cash And Cash Equivalents 43,800,113
Short-term Investments 16,780,883
Net Receivables 73,661,191
Inventory 53,923,283
Other Current Assets 59,834
Total Current Assets  (as reported)198,935,276
Total Current Assets  (calculated)188,225,305
+/- 10,709,971
Long-term Assets
Property Plant Equipment 118,637,815
Intangible Assets 5,769,314
Long-term Assets Other 35,937
Long-term Assets  (as reported)151,148,364
Long-term Assets  (calculated)124,443,066
+/- 26,705,298

Liabilities & Shareholders' Equity

Total Current Liabilities76,384,881
Long-term Liabilities2,916,614
Total Stockholder Equity269,585,828
Total Current Liabilities
Short Long Term Debt 45,000,000
Accounts payable 8,941,407
Other Current Liabilities 3,839,830
Total Current Liabilities  (as reported)76,384,881
Total Current Liabilities  (calculated)57,781,237
+/- 18,603,643
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,151,437
Long-term Liabilities Other 276,151
Long-term Liabilities  (as reported)2,916,614
Long-term Liabilities  (calculated)1,427,588
+/- 1,489,027
Total Stockholder Equity
Retained Earnings 55,331,340
Total Stockholder Equity (as reported)269,585,828
Total Stockholder Equity (calculated)55,331,340
+/- 214,254,488
Other
Capital Stock27,592,495
Common Stock Shares Outstanding 49,271
Net Debt 1,199,887
Net Invested Capital 313,485,828
Net Working Capital 122,550,395
Property Plant and Equipment Gross 249,536,244



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
400,680,155
399,683,711
390,629,924
382,685,877
391,647,359
390,327,951
385,129,325
392,884,671
395,509,541
390,278,757
380,113,704
390,237,607
390,560,900
602,603,322
487,149,865
465,806,713
427,096,821
416,053,208
392,584,583
388,625,426
388,369,515
380,402,946
361,536,058
387,416,384
377,433,587
383,428,831
350,083,640
350,083,640383,428,831377,433,587387,416,384361,536,058380,402,946388,369,515388,625,426392,584,583416,053,208427,096,821465,806,713487,149,865602,603,322390,560,900390,237,607380,113,704390,278,757395,509,541392,884,671385,129,325390,327,951391,647,359382,685,877390,629,924399,683,711400,680,155
   > Total Current Assets 
223,337,778
222,624,142
218,828,497
218,821,072
229,914,238
230,810,807
228,782,227
233,442,421
232,793,183
229,531,505
219,191,528
233,816,696
231,008,480
445,599,344
332,811,722
317,618,490
280,774,891
269,132,892
227,231,841
224,052,584
222,291,205
215,509,414
196,541,781
222,738,324
209,514,996
214,698,046
198,935,276
198,935,276214,698,046209,514,996222,738,324196,541,781215,509,414222,291,205224,052,584227,231,841269,132,892280,774,891317,618,490332,811,722445,599,344231,008,480233,816,696219,191,528229,531,505232,793,183233,442,421228,782,227230,810,807229,914,238218,821,072218,828,497222,624,142223,337,778
       Cash And Cash Equivalents 
19,761,739
22,132,438
19,422,304
26,513,142
24,648,181
27,676,580
37,168,872
33,954,757
27,334,872
21,599,635
23,374,208
27,325,322
27,245,164
245,367,025
55,802,611
63,870,295
54,405,917
51,657,446
27,636,741
30,131,445
33,565,782
38,379,759
41,690,733
49,181,819
48,121,764
58,917,842
43,800,113
43,800,11358,917,84248,121,76449,181,81941,690,73338,379,75933,565,78230,131,44527,636,74151,657,44654,405,91763,870,29555,802,611245,367,02527,245,16427,325,32223,374,20821,599,63527,334,87233,954,75737,168,87227,676,58024,648,18126,513,14219,422,30422,132,43819,761,739
       Short-term Investments 
18,108,677
18,293,106
18,755,232
19,286,649
13,755,226
9,318,761
9,616,033
38,469,875
42,925,301
45,879,249
43,069,078
48,809,845
47,299,299
47,726,156
134,836,740
108,979,351
82,328,866
82,867,745
65,065,032
54,089,727
50,238,152
39,309,367
14,225,817
30,668,036
24,659,408
17,029,538
16,780,883
16,780,88317,029,53824,659,40830,668,03614,225,81739,309,36750,238,15254,089,72765,065,03282,867,74582,328,866108,979,351134,836,74047,726,15647,299,29948,809,84543,069,07845,879,24942,925,30138,469,8759,616,0339,318,76113,755,22619,286,64918,755,23218,293,10618,108,677
       Net Receivables 
143,634,793
137,392,567
132,784,555
122,731,383
124,692,155
122,695,097
115,792,544
111,757,691
109,609,872
108,849,727
101,771,208
101,283,669
100,171,212
95,776,196
91,013,889
91,110,930
93,338,805
84,808,599
84,159,383
84,135,078
83,642,247
84,684,865
90,575,586
75,802,941
83,878,485
72,630,573
73,661,191
73,661,19172,630,57383,878,48575,802,94190,575,58684,684,86583,642,24784,135,07884,159,38384,808,59993,338,80591,110,93091,013,88995,776,196100,171,212101,283,669101,771,208108,849,727109,609,872111,757,691115,792,544122,695,097124,692,155122,731,383132,784,555137,392,567143,634,793
       Inventory 
41,120,010
43,785,615
46,929,277
48,872,514
45,826,728
46,987,907
44,937,943
45,752,432
46,086,564
48,706,664
49,025,537
54,772,906
54,923,541
54,661,512
49,088,332
51,845,264
49,123,719
47,473,855
47,706,504
50,547,836
52,962,075
47,400,021
46,895,168
51,890,151
51,058,755
51,806,592
53,923,283
53,923,28351,806,59251,058,75551,890,15146,895,16847,400,02152,962,07550,547,83647,706,50447,473,85549,123,71951,845,26449,088,33254,661,51254,923,54154,772,90649,025,53748,706,66446,086,56445,752,43244,937,94346,987,90745,826,72848,872,51446,929,27743,785,61541,120,010
       Other Current Assets 
563,437
656,810
639,416
1,214,058
6,019,318
5,429,686
1,142,022
1,020,588
694,115
935,561
1,358,344
1,339,325
1,292,666
1,240,329
1,174,219
1,223,760
1,242,395
1,253,917
1,763,703
4,503,065
1,429,458
4,592,969
2,146,888
35,587
1,380,916
39,748
59,834
59,83439,7481,380,91635,5872,146,8884,592,9691,429,4584,503,0651,763,7031,253,9171,242,3951,223,7601,174,2191,240,3291,292,6661,339,3251,358,344935,561694,1151,020,5881,142,0225,429,6866,019,3181,214,058639,416656,810563,437
   > Long-term Assets 
0
0
0
0
0
0
0
159,442,251
162,716,358
160,747,252
160,922,175
156,420,911
159,552,420
157,003,978
154,338,143
148,188,223
146,321,929
146,920,316
165,352,742
164,572,842
166,078,310
164,893,531
164,994,277
164,678,060
167,918,590
168,730,785
151,148,364
151,148,364168,730,785167,918,590164,678,060164,994,277164,893,531166,078,310164,572,842165,352,742146,920,316146,321,929148,188,223154,338,143157,003,978159,552,420156,420,911160,922,175160,747,252162,716,358159,442,2510000000
       Property Plant Equipment 
140,726,841
139,309,204
138,192,046
135,608,404
133,521,899
131,633,197
130,504,647
132,377,744
131,983,881
133,203,527
130,942,363
130,219,340
127,819,208
125,616,671
124,177,497
122,524,390
120,833,243
119,569,124
116,883,611
116,229,327
116,780,317
116,008,150
113,759,902
114,421,365
119,295,518
120,464,001
118,637,815
118,637,815120,464,001119,295,518114,421,365113,759,902116,008,150116,780,317116,229,327116,883,611119,569,124120,833,243122,524,390124,177,497125,616,671127,819,208130,219,340130,942,363133,203,527131,983,881132,377,744130,504,647131,633,197133,521,899135,608,404138,192,046139,309,204140,726,841
       Long Term Investments 
17,278,033
19,081,133
17,490,612
12,487,305
12,415,380
12,846,193
10,096,851
11,479,697
14,136,933
10,840,848
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000010,840,84814,136,93311,479,69710,096,85112,846,19312,415,38012,487,30517,490,61219,081,13317,278,033
       Intangible Assets 
11,582,453
11,375,243
8,784,291
8,553,644
8,343,486
7,295,107
7,119,876
6,918,514
7,921,264
8,198,701
8,914,284
8,587,919
8,485,200
8,547,512
8,062,013
7,889,039
8,421,233
8,131,064
8,970,638
7,470,512
7,643,132
7,362,645
6,930,822
6,659,527
6,330,833
6,098,826
5,769,314
5,769,3146,098,8266,330,8336,659,5276,930,8227,362,6457,643,1327,470,5128,970,6388,131,0648,421,2337,889,0398,062,0138,547,5128,485,2008,587,9198,914,2848,198,7017,921,2646,918,5147,119,8767,295,1078,343,4868,553,6448,784,29111,375,24311,582,453
       Long-term Assets Other 
0
0
0
0
0
0
0
159,442,251
0
0
160,922,175
156,420,911
0
0
0
0
0
0
0
0
0
0
-628,436
-625,984
-497,346
37,162
35,937
35,93737,162-497,346-625,984-628,4360000000000156,420,911160,922,17500159,442,2510000000
> Total Liabilities 
180,032,099
175,941,623
175,500,791
173,005,677
179,078,732
177,064,115
173,471,103
179,399,732
178,688,227
174,567,065
170,985,479
178,974,064
176,745,651
219,485,350
112,819,609
99,217,386
59,776,921
49,234,504
38,025,375
39,320,291
43,141,070
41,174,722
30,777,771
62,772,023
61,786,835
76,020,807
79,301,495
79,301,49576,020,80761,786,83562,772,02330,777,77141,174,72243,141,07039,320,29138,025,37549,234,50459,776,92199,217,386112,819,609219,485,350176,745,651178,974,064170,985,479174,567,065178,688,227179,399,732173,471,103177,064,115179,078,732173,005,677175,500,791175,941,623180,032,099
   > Total Current Liabilities 
145,074,482
140,763,219
139,075,968
135,243,783
149,662,815
147,561,092
146,170,853
147,678,735
147,680,838
140,542,011
133,953,360
139,046,896
136,011,847
159,195,481
83,337,026
69,207,316
40,139,711
31,138,700
28,550,129
27,988,649
32,399,025
29,855,133
27,167,238
59,356,152
59,097,037
72,386,155
76,384,881
76,384,88172,386,15559,097,03759,356,15227,167,23829,855,13332,399,02527,988,64928,550,12931,138,70040,139,71169,207,31683,337,026159,195,481136,011,847139,046,896133,953,360140,542,011147,680,838147,678,735146,170,853147,561,092149,662,815135,243,783139,075,968140,763,219145,074,482
       Short-term Debt 
117,032,332
750,000
500,000
250,000
4,550,000
4,550,000
0
102,953,203
102,621,646
98,330,000
98,506,689
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000098,506,68998,330,000102,621,646102,953,20304,550,0004,550,000250,000500,000750,000117,032,332
       Short Long Term Debt 
117,032,332
750,000
500,000
250,000
4,550,000
4,550,000
0
102,953,203
102,621,646
98,330,000
98,506,689
96,532,749
96,313,388
77,477,567
150,166
5,920
9,979,802
162,271
248,111
0
138,637
0
0
30,000,000
30,000,000
45,000,000
45,000,000
45,000,00045,000,00030,000,00030,000,00000138,6370248,111162,2719,979,8025,920150,16677,477,56796,313,38896,532,74998,506,68998,330,000102,621,646102,953,20304,550,0004,550,000250,000500,000750,000117,032,332
       Accounts payable 
21,646,605
21,821,733
25,175,260
21,224,356
20,699,391
19,928,500
21,163,837
20,183,918
22,699,199
21,115,339
18,373,184
23,243,848
21,446,997
17,922,102
8,788,909
12,831,658
12,148,652
12,350,086
12,060,475
12,441,849
12,126,020
9,008,858
11,428,317
12,001,280
12,891,185
11,707,180
8,941,407
8,941,40711,707,18012,891,18512,001,28011,428,3179,008,85812,126,02012,441,84912,060,47512,350,08612,148,65212,831,6588,788,90917,922,10221,446,99723,243,84818,373,18421,115,33922,699,19920,183,91821,163,83719,928,50020,699,39121,224,35625,175,26021,821,73321,646,605
       Other Current Liabilities 
12,373,376
9,550,885
6,202,102
8,516,778
20,199,887
20,123,784
15,311,677
4,967,836
4,621,435
4,603,194
11,981,508
15,063,683
13,576,904
58,305,370
68,385,744
49,375,029
10,711,998
10,292,333
8,464,812
8,295,252
10,172,552
6,669,987
3,338,998
3,325,327
6,468,829
3,214,888
3,839,830
3,839,8303,214,8886,468,8293,325,3273,338,9986,669,98710,172,5528,295,2528,464,81210,292,33310,711,99849,375,02968,385,74458,305,37013,576,90415,063,68311,981,5084,603,1944,621,4354,967,83615,311,67720,123,78420,199,8878,516,7786,202,1029,550,88512,373,376
   > Long-term Liabilities 
0
0
0
0
0
0
0
31,720,997
31,007,389
34,025,054
37,032,119
39,927,168
40,733,804
60,289,870
29,482,583
30,010,070
19,637,210
18,095,804
9,475,246
11,331,642
10,742,046
11,319,589
3,610,533
3,415,871
2,689,798
3,634,651
2,916,614
2,916,6143,634,6512,689,7983,415,8713,610,53311,319,58910,742,04611,331,6429,475,24618,095,80419,637,21030,010,07029,482,58360,289,87040,733,80439,927,16837,032,11934,025,05431,007,38931,720,9970000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
1,036,490
876,478
666,010
433,815
784,454
956,976
1,176,921
1,635,104
1,544,525
1,384,895
1,229,614
932,602
1,580,203
2,128,205
2,301,705
1,928,274
1,608,609
1,366,188
1,469,999
1,151,437
1,151,4371,469,9991,366,1881,608,6091,928,2742,301,7052,128,2051,580,203932,6021,229,6141,384,8951,544,5251,635,1041,176,921956,976784,454433,815666,010876,4781,036,4900000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1,007,545
494,229
494,228
276,151
276,151494,228494,2291,007,54500100000000000000000000
> Total Stockholder Equity
219,261,729
222,353,478
213,729,532
208,269,875
211,113,981
211,820,395
209,545,567
212,443,938
215,745,775
214,569,617
208,183,651
210,235,945
212,827,596
382,118,054
373,371,492
365,591,682
366,293,742
365,752,915
353,491,907
348,197,938
344,039,571
337,993,459
329,607,246
323,471,595
314,441,024
306,182,058
269,585,828
269,585,828306,182,058314,441,024323,471,595329,607,246337,993,459344,039,571348,197,938353,491,907365,752,915366,293,742365,591,682373,371,492382,118,054212,827,596210,235,945208,183,651214,569,617215,745,775212,443,938209,545,567211,820,395211,113,981208,269,875213,729,532222,353,478219,261,729
   Common Stock
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
26,492,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
27,592,495
0
0
27,592,495
0
0
0027,592,4950027,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49527,592,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,49526,492,495
   Retained Earnings 
151,351,152
154,255,530
148,218,139
148,220,946
150,318,911
151,150,771
147,841,325
144,563,530
146,999,854
147,831,734
146,462,504
148,713,143
150,519,125
154,271,361
156,595,484
152,884,907
153,274,725
151,302,049
139,159,599
133,826,800
129,227,817
120,774,565
115,830,156
108,795,404
99,797,123
91,745,520
55,331,340
55,331,34091,745,52099,797,123108,795,404115,830,156120,774,565129,227,817133,826,800139,159,599151,302,049153,274,725152,884,907156,595,484154,271,361150,519,125148,713,143146,462,504147,831,734146,999,854144,563,530147,841,325151,150,771150,318,911148,220,946148,218,139154,255,530151,351,152
   Accumulated Other Comprehensive Income 000000000000000000000000000
   Capital Surplus 000000000000000000000000000
   Treasury Stock000000000000000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue200,228,583
Cost of Revenue-119,951,150
Gross Profit80,277,43280,277,432
 
Operating Income (+$)
Gross Profit80,277,432
Operating Expense-247,620,987
Operating Income-47,392,405-167,343,555
 
Operating Expense (+$)
Research Development42,276,758
Selling General Administrative36,865,890
Selling And Marketing Expenses0
Operating Expense247,620,98779,142,648
 
Net Interest Income (+$)
Interest Income1,173,692
Interest Expense-1,718,660
Other Finance Cost-0
Net Interest Income-544,968
 
Pretax Income (+$)
Operating Income-47,392,405
Net Interest Income-544,968
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-53,441,796-47,392,405
EBIT - interestExpense = -1,718,660
-57,325,387
-55,606,727
Interest Expense1,718,660
Earnings Before Interest and Taxes (EBIT)0-51,723,136
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-53,441,796
Tax Provision-3,830,735
Net Income From Continuing Ops-57,272,532-57,272,532
Net Income-57,325,387
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0544,968
 

Technical Analysis of Shinpoong
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Shinpoong. The general trend of Shinpoong is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Shinpoong's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Shinpoong Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 31,200 < 38,300 < 39,000.

The bearish price targets are: 23,500 > 17,750 > 17,530.

Tweet this
Shinpoong Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Shinpoong Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shinpoong Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Shinpoong Pharmaceutical Co Ltd. The current macd is 529.89.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Shinpoong price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Shinpoong. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Shinpoong price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Shinpoong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartShinpoong Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Shinpoong Pharmaceutical Co Ltd. The current adx is 49.18.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Shinpoong shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Shinpoong Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Shinpoong Pharmaceutical Co Ltd. The current sar is 31,134.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Shinpoong Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Shinpoong Pharmaceutical Co Ltd. The current rsi is 47.80. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Shinpoong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartShinpoong Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Shinpoong Pharmaceutical Co Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Shinpoong price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Shinpoong Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartShinpoong Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Shinpoong Pharmaceutical Co Ltd. The current cci is -90.0481672.

Shinpoong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartShinpoong Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Shinpoong Pharmaceutical Co Ltd. The current cmo is -12.30150146.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Shinpoong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartShinpoong Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Shinpoong Pharmaceutical Co Ltd. The current willr is -89.958159.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Shinpoong Pharmaceutical Co Ltd Daily Williams %R ChartShinpoong Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Shinpoong Pharmaceutical Co Ltd.

Shinpoong Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Shinpoong Pharmaceutical Co Ltd. The current atr is 2,545.

Shinpoong Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartShinpoong Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Shinpoong Pharmaceutical Co Ltd. The current obv is 3,205,349.

Shinpoong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartShinpoong Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Shinpoong Pharmaceutical Co Ltd. The current mfi is 67.24.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Shinpoong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartShinpoong Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Shinpoong Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Shinpoong Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Shinpoong Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.804
Ma 20Greater thanMa 5026,855.000
Ma 50Greater thanMa 10021,923.600
Ma 100Greater thanMa 20021,100.300
OpenGreater thanClose24,500.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Shinpoong with someone you think should read this too:
  • Are you bullish or bearish on Shinpoong? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Shinpoong? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Shinpoong Pharmaceutical Co Ltd

I send you an email if I find something interesting about Shinpoong Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Shinpoong Pharmaceutical Co Ltd.

Receive notifications about Shinpoong Pharmaceutical Co Ltd in your mailbox!